Newsroom

JULY 13 2021 Sean Whooley Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Additionally, Messler will be supporting the delivery, customer, quality...

Engineering and Technology Veteran to Lead Company’s Product Vision and Support Growing Demand for Insulin Dosing Software and Inpatient Glycemic Management WALTHAM, MASS. (June 22, 2021) –  Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced the appointment of Nausheen Moulana as Chief Technology Officer. In this role, Moulana will...

APRIL 26 2021 Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million debt financing from...

APRIL 26 2021 WALTHAM, MA, Glytec, a provider of insulin management software, announced $21 million in financing. Glytec, a provider of insulin management software, announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding includes $9 million debt financing from SVB and a $12 million equity investment led by Savitr. Glytec is an...

MAY 13 2021 Amanda Pedersen Finalists in the 2021 Medical Design Excellence Awards program shared best practices and lessons learned from the design process. These were among the most compelling takeaways from the discussions. The Medtech Design Summit is available to watch on demand here. View slideshow: ...

MAY 13 2021 SANTA MONICA, Calif.--(BUSINESS WIRE)--Medical Design Excellence Awards (MDEA), a prestigious award program recognizing cutting-edge achievements in medical product design, today announced the 2021 winners during the all-new Medtech Design Summit, during which Novo; Protolabs; HS Design, a SteriPack company; and Trelleborg sponsored sessions and Bressler Group, Inertia Engineering,...

APRIL 26 2021 Fred Pennic What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized...

APRIL 26 2021 WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. Editor's Note: This article originally posted on Glytec's website. The funding will fuel Glytec’s mission of revolutionizing the role glycemic...

APRIL 27 2021 Mallory Hackett The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. The company collected $9 million in debt financing from...

APRIL 26 2021 Sean Whooley Glytec announced today that it raised $21 million in financing to fund its glycemic management technology. Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a news release. The company said it plans to use...